Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Dementia Treatment Market

Dementia Treatment Market Trends

  • Report ID: GMI9342
  • Published Date: May 2024
  • Report Format: PDF

Dementia Treatment Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as growing focus on early detection and intervention, advancements in precision medicine, rise of disease-modifying therapies, and surging need of integrated digital health solutions, among other factors are propelling the industry growth.
 

  • Further, there is a growing emphasis on early detection of dementia through screening programs, biomarker research, and diagnostic innovations. Early diagnosis enables timely intervention with pharmacological and non-pharmacological treatments, lifestyle modifications, and support services, potentially delaying disease progression and improving outcomes.
     
  • Moreover, digital health technologies, such as telemedicine, remote monitoring, mobile apps, wearable medical devices, and artificial intelligence in healthcare, are revolutionizing dementia care delivery and management. These technologies enable remote assessment, monitoring, and communication between patients, caregivers, and healthcare providers, enhancing access to care and optimizing treatment outcomes, thereby aforementioned factors are expected to drive the market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The dementia treatment market was valued at USD 17.7 billion in 2023 and is expected to exhibit growth at 7.6% CAGR from 2024

The cholinesterase inhibitors segment in the dementia treatment industry generated USD 8 billion in 2023, owing to ongoing research efforts focused on improving the efficacy, safety, and tolerability of ChEIs.

North America dementia treatment market size was USD 6.7 billion in 2023 and is anticipated to grow at 7.4% CAGR between 2024

AbbVie Inc., Biogen, Cipla Inc., Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Sun Pharmaceutical Industries Ltd., Eli Lilly and Company, Merck & Co., Inc., Novartis AG and Otsuka Pharmaceutical Co., Ltd.

Dementia Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 150
  • Countries covered: 23
  • Pages: 110
 Download Free Sample